🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Bülent Özpolat

Houston Methodist

ORCID: 0000-0001-8602-7463

Also affiliated with University of Oklahoma

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer”.

Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer

Pharmaceutical Research(2022)10.1007/s11095-022-03176-3
N/A
0.494DataRank · unranked
26 citations

Javier Ruiz-Ramírez, Joseph D. Butner, María J. Peláez, Caroline Chung, Anupama Hooda-Nehra +7 more

Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple Negative Breast Cancer

medRxiv(2021)10.1101/2021.10.19.21265154
N/A
0.175DataRank · unranked
2 citations

Javier Ruiz-Ramírez, Joseph D. Butner, María J. Peláez, Caroline Chung, Anupama Hooda-Nehra +7 more

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer

medRxiv(2024)10.1101/2024.03.14.24304306
N/A
0.165DataRank · unranked
2 citations

Vrushaly Shinglot, Javier Ruiz-Ramírez, Joseph Cave, Joseph D. Butner, Carmine Schiavone +9 more

ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer

Molecular Therapy — Nucleic Acids(2021)10.1016/j.omtn.2021.01.016
N/A
0DataRank · unranked
51 citations

Recep Bayraktar, Cristina Ivan, Hamada A. Mokhlis, Emine Bayraktar, Nermin Kahraman +12 more

Redirecting host preexisting influenza A virus immunity for cancer immunotherapy

Cancer Immunology Immunotherapy(2021)10.1007/s00262-021-03099-9
N/A
0DataRank · unranked
4 citations

Songbo Qiu, Lu Yang, Gabriel Lopez‐Berestein, Bülent Özpolat, Zhen Fan +1 more

Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]

EBioMedicine(2020)10.1016/j.ebiom.2020.102630
N/A
0DataRank · unranked
7 citations

Recep Bayraktar, Merve Denizli, Mohammed H. Rashed, Cristina Ivan, Burcu Aslan +15 more

Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study

Cell Death and Disease(2022)10.1038/s41419-022-04939-x
N/A
0DataRank · unranked
17 citations

Prashant Dogra, Caroline Chung, Javier Ruiz-Ramírez, Sara Nizzero, Marija Plodinec +8 more

Mechanistic modeling of anti-microRNA-155 therapy combinations in lung cancer

PubMed(2023)10.1109/embc40787.2023.10341114
N/A
0DataRank · unranked
9 citations

Vrushaly Shinglot, Joseph D. Butner, Vittorio Cristini, Bülent Özpolat, George A. Calin +3 more

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer

Molecular Cancer(2024)10.1186/s12943-024-02060-5
N/A
0DataRank · unranked
24 citations

Vrushaly Shinglot, Javier Ruiz-Ramírez, Joseph Cave, Joseph D. Butner, Carmine Schiavone +9 more

The Role of Nanomedicine in Benign Gynecologic Disorders

Molecules(2024)10.3390/molecules29092095
N/A
0DataRank · unranked
15 citations

Malini Ramaiyer, Rachel Michel, Ahmed S. Saad, Bülent Özpolat, Mostafa A. Borahay +1 more

Corrections to “A Multiscale Agent-Based Model of Ductal Carcinoma in Situ” [May 20 1450-1461]

IEEE Transactions on Biomedical Engineering(2021)10.1109/tbme.2020.3044508
N/A
0DataRank · unranked
0 citations

David Fuentes, Bülent Özpolat, George A. Calin, Xiaobo Zhou, John Lowengrub +3 more

Novel Inhibitors of Eukaryotic Elongation Factor 2 Kinase: In Silico, Synthesis, and in Vitro Studies

ChemRxiv(2020)10.26434/chemrxiv.13299149.v1
N/A
0DataRank · unranked
1 citations

Serdar Durdağı, Nermin Kahraman, Tuğçe Nur Uslu, Hakan Kandemir, Esen Bellur Atıcı +3 more

Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002086
N/A
0DataRank · unranked
53 citations

Teresa T. Nguyen, Bülent Özpolat, Frederick F. Lang, Marta M. Alonso, Candelaria Gomez‐Manzano +2 more